Detail
LncRNA Name | MEG3 |
Synonyms | MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1 |
Region | GRCh38_14:100779410-100861031 Sequence |
Ensembl | ENSG00000214548 |
RefSeq | NR_002766 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✔ |
Cancer Name | acute myeloid leukemia |
ICD-0-3 | M9861/3 |
Methods | MSP-PCR etc. |
Sample | bone marrow |
Expression Pattern | down-regulated |
Function Description | MEG3 hypermethylation occurred in 15 MDS patients (34.9%), and in 20 AML patients (47.6%). SNRPN hypermethylation was observed in 15 MDS patients (34.9%), and in 21 AML patients (50%). There were no significant correlations between WHO subtype, WPSS score, karyotype, haemoglobin levels, white blood cell count, platelet count and CpG methylation of any gene. MEG3 hypermethylation was associated with significantly reduced overall survival in individuals with AML, while SNRPN CpG methylation was not associated with survival. |
Pubmed ID | 19595458 |
Year | 2010 |
Title | CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. |
External Links |
Links for MEG3 | GenBank HGNC lncrnadb Noncode |
Links for acute myeloid leukemia | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.